Panion & Bf Biotech Inc. (TPE:1760)
63.70
-0.10 (-0.16%)
Jan 22, 2026, 12:58 PM CST
Panion & Bf Biotech Revenue
Panion & Bf Biotech had revenue of 531.95M TWD in the quarter ending September 30, 2025, with 6.13% growth. This brings the company's revenue in the last twelve months to 2.04B, up 0.20% year-over-year. In the year 2024, Panion & Bf Biotech had annual revenue of 2.03B with 7.85% growth.
Revenue (ttm)
2.04B
Revenue Growth
+0.20%
P/S Ratio
2.68
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.03B | 147.77M | 7.85% |
| Dec 31, 2023 | 1.88B | -516.77M | -21.54% |
| Dec 31, 2022 | 2.40B | 497.44M | 26.16% |
| Dec 31, 2021 | 1.90B | 332.57M | 21.20% |
| Dec 31, 2020 | 1.57B | -5.31M | -0.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinphar Pharmaceutical | 3.35B |
| Medigen Biotechnology | 1.59B |
| Savior Lifetec | 1.16B |
| BioGend Therapeutics | 212.43M |
| Pharmosa Biopharm | 136.72M |
| OBI Pharma | 49.29M |
| UnicoCell Biomed | 34.58M |
| AnnJi Pharmaceutical | 23.85M |